B.Pharm Lab. Instruction Manuals

Pharmacology I

APHE Anatomy, Physiology, and Health Education

Pharmaceutical Analysis

Pharmacy study material

Bones and Skeleton System

Bone disease (Gout) (Rheumatoid arthritis) (Osteoarthritis) (Osteoporosis)

Cancer and music therapy

Memory of water

Dosage and monitoring tests for anti-rheumatoid drugs


Common mechanism of action

Chlorquine and Hydroxychlorquine act by inhibiting IL-1.

Major adverse drug reactions (ADRs)

Blindness, haemolysis in the glucose 6 phosphate dehydrogenase deficient persons.

Monitoring test

Baseline: color fundus photography and automated central perimetric analysis ophthalmoscopy every 9-12 months and Amsler grid at home every 2 weeks


Oral: 200-300 mg twice daily; after 1-2 months may decrease to 200 mg once or twice daily.


Common mechanism of action

Free radical scavenger.

Major adverse drug reactions (ADRs)

Folic acid deficiency followed by anemia.

Monitoring test

Baseline: CBC with platelets, then every week for 1 month and then in every 1-2 months.


Oral: 500 mg twice daily, then increase to 1 g twice daily max.

< Prev.Page   1   2   3   4  5  6   7   8   9   10  11  12   13   Next page>